483
Olympus Corporation of the AmericasOlympus Corporation of the Americas – FDA 483, Mar 10, 2022
Record Details
An FDA inspection of Olympus Corporation of the Americas in San Jose, CA, revealed significant deficiencies in their quality system. The firm failed to establish adequate procedures for medical device reporting, ensure proper employee training on adverse event awareness, and effectively manage corrective and preventive actions. Additionally, issues were noted with complaint handling processes and the validation of software used for complaint management.
View Company Profile
ID · bb2c514d-3f00-460e-9c8c-81b6efb7005b
Other documents for Olympus Corporation of the Americas
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.